. home.aspx



U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?

June 27, 2019 / Arlene Weintraub

In May, Gilead pledged to donate 2.4 million bottles of its HIV drug Truvada to the U.S. governments effort to eradicate the disease, partly by preventing new infections. Gilead even promised it would donate its newer drug, Descovy, if the FDA approves it for prevention as it did for Truvada. But now Gilead is facing accusations that its largesse may have suspicious underpinnings. On Wednesday the House Oversight Committee’s chairman, Rep. Elijah E. Cummings (D-MD), and three colleagues sent a letter (PDF) to Gilead demanding details about what led to the company’s generous offer. Specifically, the committee wants to know if the Truvada donation involved negotiations between Gilead and the Department of Health and Human Services (HHS) over patents on the product. A spokesperson for Gilead said in an email to FiercePharma that the company is “reviewing the full scope of the request and will respond to the committee in a timely manner.” Gilead has been under fire ...